Defining anxious depression: A review of the literature

CNS Spectrums

Volumn 18, Issue 5, 2013, Pages 252-260

  Ionescu, Dawn F ^a   Niciu, Mark J ^a   Henter, Ioline D ^a   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; anxious depression; depression; diagnosis; DSM 5; mixed anxiety depressive disorder

Indexed keywords

ANXIOUS DEPRESSION; DEPRESSION; DISEASE SEVERITY; DSM-5; DSM-IV; FAMILY HISTORY; FOLLOW UP; HAMILTON SCALE; HUMAN; ICD-10; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; SYMPTOM ASSESSMENT;

ANXIETY DISORDERS; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES;

EID: 84883809189     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852913000114     Document Type: Review

References (38)

1. Fava M, Rankin MA, Wright EC, et al. Anxiety disorders in major depression. Compr Psychiatry. 2000; 41(2): 97-102. (Pubitemid 30149018)
2. Sanderson WC, Beck AT, Beck J. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry. 1990; 147(8): 1025-1028. (Pubitemid 20257514)
3. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry. 2002; 63(3): 187-193. (Pubitemid 34407076)
4. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry. 1972; 26(1): 57-63.
5. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th rev. ed. Geneva: World Health Organization; 1992.
6. Walters K, Buszewicz M, Weich S, King M. Mixed anxiety and depressive disorder outcomes: prospective cohort study in primary care. Br J Psychiatry. 2011; 198(6): 472-478.
7. Wittchen HU, Essau CA. Comorbidity and mixed anxiety-depressive disorders: is there epidemiologic evidence J Clin Psychiatry. 1993; 54(suppl): 9-15. (Pubitemid 23052455)
8. Barkow K, Heun R, Wittchen HU, et al. Mixed anxiety-depression in a 1 year follow-up study: shift to other diagnoses or remission J Affect Disord. 2004; 79(1-3): 235-239. (Pubitemid 38340549)
9. Stein MB, Kirk P, Prabhu V, Grott M, Terepa M. Mixed anxiety-depression in a primary-care clinic. J Affect Disord. 1995; 34(2): 79-84.
10. Das-Munshi J, Goldberg D, Bebbington PE, et al. Public health significance of mixed anxiety and depression: beyond current classification. Br J Psychiatry. 2008; 192(3): 171-177. (Pubitemid 351347374)
11. American Psychiatric Association, Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th ed. Washington, DC: American Psychiatric Association; 1994.
12. Zinbarg RE, Barlow DH, Liebowitz M, et al. The DSM-IV field trial for mixed anxiety-depression. Am J Psychiatry. 1994; 151(8): 1153-1162. (Pubitemid 24240958)
13. Weisberg RB, Maki KM, Culpepper L, Keller MB. Is anyone really M.A.D. The occurrence and course of mixed anxiety-depressive disorder in a sample of primary care patients. J Nerv Ment Dis. 2005; 193(4): 223-230.
14. Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, et al. In search of mixed anxiety-depressive disorder: a primary care study. Depress Anxiety. 2006; 23(4): 183-189. (Pubitemid 44147903)
15. Spijker J, Batelaan N, de Graaf R, Cuijpers P. Who is MADD Mixed anxiety depressive disorder in the general population. J Affect Disord. 2010; 121(1-2): 180-183.
16. Balestrieri M, Isola M, Quartaroli M, Roncolato M, Bellantuono C. Assessing mixed anxiety-depressive disorder: a national primary care survey. Psychiatry Res. 2010; 176(2-3): 197-201.
17. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. In press. DOI: 10.1176/appi.ajp.2012.12070999.
18. Batelaan NM, Spijker J, de Graaf R, Cuijpers P. Mixed anxiety depression should not be included in DSM-5. J Nerv Ment Dis. 2012; 200(6): 495-498.
19. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004; 34(7): 1299-1308. (Pubitemid 39517160)
20. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008; 165(3): 342-351. (Pubitemid 351704490)
21. Fava M, Rush AJ, Alpert JE, et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry. 2006; 51(13): 823-835. (Pubitemid 46354060)
22. Wiethoff K, Bauer M, Baghai TC, et al. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry. 2010; 71(8): 1047-1054.
23. Cleary P, Guy W. Factor analysis of the Hamilton depression scale. Drugs Exp Clin Res. 1977(1): 115-120.
24. Seo HJ, Jung YE, Kim TS, et al. Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression. J Nerv Ment Dis. 2011; 199(1): 42-48.
25. Silverstone PH, von Studnitz E. Defining anxious depression: going beyond comorbidity. Can J Psychiatry. 2003; 48(10): 675-680. (Pubitemid 37522540)
26. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry. 1991; 148(11): 1512-1517.
27. Fawcett J, Scheftner WA, Fogg L, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990; 147(9): 1189-1194. (Pubitemid 20275373)
28. Joffe RT, Bagby RM, Levitt A. Anxious and nonanxious depression. Am J Psychiatry. 1993; 150(8): 1257-1258. (Pubitemid 23218913)
29. Farabaugh A, Alpert J, Wisniewski SR, et al. Cognitive therapy for anxious depression in STAR(*)D: what have we learned J Affect Disord. 2012; 142(1-3): 213-218.
30. Papakostas GI, Fan H, Tedeschini E. Severe and anxious depression: combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol. 2012; 22(5): 347-355.
31. Tyrer P, Seivewright H, Simmonds S, Johnson T. Prospective studies of cothymia (mixed anxiety-depression): how do they inform clinical practice Eur Arch Psychiatry Clin Neurosci. 2001; 251(suppl 2): II53-II56.
32. Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2011; 133(1-2): 76-85.
33. Nock MK, Hwang I, Sampson N, et al. Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med. 2009; 6(8): e1000123.
34. Pfeiffer PN, Ganoczy D, Ilgen M, Zivin K, Valenstein M. Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety. 2009; 26(8): 752-757.
35. Jeste ND, Hays JC, Steffens DC. Clinical correlates of anxious depression among elderly patients with depression. J Affect Disord. 2006; 90(1): 37-41. (Pubitemid 43005035)
36. Diefenbach GJ, Disch WB, Robison JT, Baez E, Coman E. Anxious depression among Puerto Rican and African-American older adults. Aging Ment Health. 2009; 13(1): 118-126.
37. Middeldorp CM, Cath DC, Beem AL, Willemsen G, Boomsma DI. Life events, anxious depression and personality: a prospective and genetic study. Psychol Med. 2008; 38(11): 1557-1565.
38. Insel TR. Next-generation treatments for mental disorders. Sci Transl Med. 2012; 4(155): 155-19.